BioMed Research International · 2014 · 289 citations · 19 references
MedicineMolecular BiologyOncologyGene ExpressionHepatologyMolecular OncologyCancer BiomarkersCirrhosisHepatocellular CarcinomaLiver CancerLiver DiseaseMicrorna BiologyBiomarker DetectionChronic Hepatitis B - Associated CarcinomaCirculating Microrna DetectionExosome-based Disease DiagnosticsExosomesHepatic BiomarkersMicrorna In CancerTumor-derived Exosomes
HCC diagnosis urgently needs new strategies, and microRNAs are increasingly viewed as disease biomarkers. The study examined serum exosomal miR‑21 expression in HCC versus chronic hepatitis B patients to assess its clinical relevance. They measured miR‑21 levels by quantitative RT‑PCR in serum exosomes, exosome‑depleted supernatants, and whole serum. Serum exosomal miR‑21 was markedly enriched compared to whole serum, was significantly higher in HCC patients than in CHB or healthy controls, correlated with cirrhosis and advanced tumor stage, and thus offers greater diagnostic sensitivity and may serve as a potential HCC biomarker.
New strategies for the diagnosis of hepatocellular carcinoma (HCC) are urgently needed. There is an increasing interest in using microRNAs (miRNAs) as biomarkers in diseases. In this study, we examined the expression of miR-21 in serum exosomes from patients with HCC or chronic hepatitis B (CHB) and investigated the potential clinical significance of miR-21. Quantitative RT-PCR indicated that the concentration of miR-21 was significantly higher in exosomes than in exosome-depleted supernatants or the whole serum. Further, the expression level of serum exosomal miR-21 was significantly higher in patients with HCC than those with CHB or healthy volunteers (P < 0.0001, P < 0.0001, resp.). High level of miR-21 expression correlated with cirrhosis (P = 0.024) and advanced tumor stage (P = 0.001). Although serum level of miR-21 was higher in patients with HCC than in patients with CHB and healthy volunteers, the sensitivity of detection is much lower than using exosomal miR-21. These findings indicate that miR-21 is enriched in serum exosomes which provides increased sensitivity of detection than whole serum. Exosomal miR-21 may serve as a potential biomarker for HCC diagnosis.
19
Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text
Global Cancer Statistics, 2002
Donald Maxwell Parkin, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2005 · 18.4K citations · Full text
MicroRNA expression profiles classify human cancers
Jun Lü, Gad Getz, Eric A. Miska et al. · Nature · 2005 · 9.6K citations